ABL will Attend BARDA Industry Day Nov. 12-14 in Washington, DC

ABL will attend Biomedical Advanced Research and Development Authority (BARDA)’s Industry Day at the Ronald Reagan Building & International Trade Center on November 12-14. ABL is interested in partnering opportunities with other companies or groups in order to successfully answer BARDA initiatives. With ABL’s long history of government contracting and expanding clinical capabilities, including GMP protein and virus manufacturing and GCLP clinical immunomonitoring, ABL is well-positioned to contribute to BARDA’s goals in 2014.

The BARDA Industry Day will focus on BARDA’s strategy, goals, and areas of interest for FY14 and beyond, new initiatives, and opportunities. BARDA supports the advanced research & development, manufacturing, acquisition, and stockpiling of medical countermeasures (drugs, biological therapeutics, vaccines, diagnostics, and non-pharmaceutical countermeasures) against CBRN threats, pandemic influenza, and emerging infectious diseases.